Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2014, Article ID 284172, 8 pages
http://dx.doi.org/10.1155/2014/284172
Research Article

Mortality in Patients on Renal Replacement Therapy and Permanent Cardiac Pacemakers

1CASMU Arrhythmia Service, 8 de Octubre 3310, 11600 Montevideo, Uruguay
2British Hospital, Avenida Italia 2420, 11600 Montevideo, Uruguay
3Uruguayan Registry of Dialysis, Uruguay
4Nephrology Clinic, Hospital de Clinicas, Faculty of Medicine, The University of the Republic, Avenida Italia s/n, 11600 Montevideo, Uruguay

Received 28 January 2014; Revised 6 April 2014; Accepted 7 April 2014; Published 26 May 2014

Academic Editor: David B. Kershaw

Copyright © 2014 Gabriel Vanerio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Raza, J.-M. Li, R. John et al., “Long-term mortality and pacing outcomes of patients with permanent pacemaker implantation after cardiac surgery,” Pacing and Clinical Electrophysiology, vol. 34, no. 3, pp. 331–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Brunner, M. Olschewski, A. Geibeli, C. Bode, and M. Zehender, “Long-term survival after pacemaker implantation: prognostic importance of gender and baseline patient characteristics,” European Heart Journal, vol. 25, no. 1, pp. 88–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Schmidt, M. Brunner, M. Olschewski et al., “Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters,” American Heart Journal, vol. 146, no. 5, pp. 908–913, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Pyatt, J. D. Somauroo, M. Jackson et al., “Long-term survival after permanent pacemaker implantation: analysis of predictors for increased mortality,” Europace, vol. 4, no. 2, pp. 113–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. US Renal Data System, USRDS, 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2008.
  6. B. Kestenbaum, K. D. Rudser, M. G. Shlipak et al., “Kidney function, electrocardiographic findings, and cardiovascular events among older adults,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 501–508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Ishikawa, “Arrhythmia and conduction abnormalities in hemodialysis patients,” Nippon Rinsho, vol. 62, pp. 237–245, 2004. View at Google Scholar · View at Scopus
  8. C. A. Herzog, “Can we prevent sudden cardiac death in dialysis patients?” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 410–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Alsheikh-Ali, T. A. Trikalinos, R. Ruthazer et al., “Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease,” American Heart Journal, vol. 161, no. 1, pp. 204.e1–209.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Arsenescu, G. I. Georgescu, A. Covic, and L. Briotǎ, “Permanent cardiac pacing for chronic symptomatic atrioventricular block in uremic hemodialysed patients. A prospective study,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Lasi, vol. 106, no. 1, pp. 112–121, 2002. View at Google Scholar · View at Scopus
  11. H. Kohno, M. Hisahara, M. Umesue et al., “Permanent cardiac pacing in patients on chronic dialysis,” Nihon Kyobu Geka Gakkai Zasshi, vol. 39, no. 7, pp. 992–995, 1991. View at Google Scholar · View at Scopus
  12. R. B. Leman, J. M. Kratz, and P. C. Gazes, “Permanent cardiac pacing in patients on chronic renal dialysis,” American Heart Journal, vol. 110, no. 6, pp. 1242–1244, 1985. View at Google Scholar · View at Scopus
  13. A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen et al., “ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices),” Journal of the American College of Cardiology, vol. 51, no. 21, pp. e1–e62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. E. Vardas, A. Auricchio, J.-J. Blanc et al., “Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association,” Europace, vol. 9, no. 10, pp. 959–998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Drew, K. B. Meyer, and D. E. Weiner, “Transvenous cardiac device wires and vascular access in hemodialysis patients,” American Journal of Kidney Diseases, vol. 58, no. 3, pp. 494–496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Asif, L. H. Salman, G. G. Lopera, and R. G. Carrillo, “The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach,” Kidney International, vol. 79, no. 12, pp. 1267–1269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Bloom, B. Heeke, A. Leon et al., “Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery,” Pacing and Clinical Electrophysiology, vol. 29, no. 2, pp. 142–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-F. Chang, B. I.-T. Kuo, T.-L. Chen, W.-C. Yang, S.-D. Lee, and C.-C. Lin, “Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center,” Journal of Nephrology, vol. 17, no. 2, pp. 228–235, 2004. View at Google Scholar · View at Scopus
  19. K. Mischke, T. Schimpf, C. Knackstedt, and P. Schauerte, “Pacemaker with 2:1 hyperkalemic ventricular exit block,” International Journal of Cardiology, vol. 116, no. 1, pp. 117–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. H. Teruya, A. M. Abou-Zamzam Jr., W. Limm, L. Wong, and L. Wong, “Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers,” Annals of Vascular Surgery, vol. 17, no. 5, pp. 526–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Cavatorta, S. Campisi, and A. Zollo, “Subclavian vein stenosis: a potentially serious complication in chronic hemodialysis patients with permanent cardiac pacemakers,” International Journal of Artificial Organs, vol. 20, no. 6, pp. 316–318, 1997. View at Google Scholar · View at Scopus
  22. N. Mazzuchi, E. Schwedt, L. Solá, C. González, and A. Ferreiro, “Risk factors and prevention of end stage renal disease in Uruguay,” Renal Failure, vol. 28, no. 8, pp. 617–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Mazzuchi, E. Schwedt, C. Gonzalez et al., “Uruguayan registry committee of dialysis: evaluation of the dialysis program for the treatment of chronic kidney disease in Uruguay,” Archives of Internal Medicine Uruguay, vol. 22, pp. 1–71, 2000. View at Google Scholar
  24. E. S. Williams, S. H. Shah, J. P. Piccini et al., “Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy,” Europace, vol. 13, no. 12, pp. 1717–1722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Tompkins, R. McLean, A. Cheng et al., “End-stage renal disease predicts complications in pacemaker and ICD implants,” Journal of Cardiovascular Electrophysiology, vol. 22, no. 10, pp. 1099–1104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Ahmed, E. Gertner, W. B. Nelson, C. M. House, and D. W. X. Zhu, “Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation,” Journal of Interventional Cardiac Electrophysiology, vol. 29, no. 3, pp. 203–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. S. Hager, S. Jain, J. Blackwell, B. Culp, J. Song, and C. D. Chiles, “Effect of renal function on survival after implantable cardioverter defibrillator placement,” American Journal of Cardiology, vol. 106, no. 9, pp. 1297–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Charytan, A. R. Patrick, J. Liu et al., “Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the united states,” American Journal of Kidney Diseases, vol. 58, no. 3, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hiremath, S. R. Punnam, S. S. Brar et al., “Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry,” American Journal of Nephrology, vol. 32, no. 4, pp. 305–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Sakhuja, M. Keebler, T.-S. Lai, C. McLaughlin Gavin, R. Thakur, and D. L. Bhatt, “Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator,” American Journal of Cardiology, vol. 103, no. 5, pp. 735–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Robin, K. Weinberg, J. Tiongson et al., “Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients,” Heart Rhythm, vol. 3, no. 10, pp. 1196–1201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. Lee, J. V. Tu, P. C. Austin et al., “Effect of cardiac and noncardiac conditions on survival after defibrillator implantation,” Journal of the American College of Cardiology, vol. 49, no. 25, pp. 2408–2415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Wase, A. Basit, R. Nazir et al., “Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients,” Journal of Interventional Cardiac Electrophysiology, vol. 11, no. 3, pp. 199–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. I. Koontz, D. Haithcock, V. Cumbea et al., “Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository,” American Heart Journal, vol. 158, no. 5, pp. 719–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Dasgupta, J. Montalvo, S. Medendorp et al., “Increased complication rates of cardiac rhythm management devices in ESRD patients,” American Journal of Kidney Diseases, vol. 49, no. 5, pp. 656–663, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Kusaba, S. Tanda, H. Kameyama et al., “Efficacy of biventricular pacing for dialysis-related hypotension due to idiopathic dilated cardiomyopathy,” Clinical and Experimental Nephrology, vol. 9, no. 3, pp. 255–259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. F. G. Hage, W. AlJaroudi, H. Aggarwal et al., “Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention,” International Journal of Cardiology, vol. 165, no. 1, pp. 113–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Lam, P. Leong-Sit, and A. X. Garg, “The role of implantable cardioverter-defibrillators in long-term dialysis patients,” American Journal of Kidney Diseases, vol. 58, no. 3, pp. 338–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. L. A. Cannizzaro, J. P. Piccini, U. D. Patel, and A. F. Hernandez, “Device therapy in heart failure patients with chronic kidney disease,” Journal of the American College of Cardiology, vol. 58, no. 9, pp. 889–896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. O. A. Ajijola, E. A. MacKlin, S. A. Moore et al., “Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome,” Europace, vol. 12, no. 12, pp. 1745–1749, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-W. Chae, C. S. Song, H. Kim, K.-B. Lee, B.-S. Seo, and D.-I. Kim, “Prediction of mortality in patients undergoing maintenance hemodialysis by Charlson Comorbidity Index using ICD-10 database,” Nephron: Clinical Practice, vol. 117, no. 4, pp. c379–c384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. US Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2010.
  43. A. J. Bleyer, G. B. Russell, and S. G. Satko, “Sudden and cardiac death rates in hemodialysis patients,” Kidney International, vol. 55, no. 4, pp. 1553–1559, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. A. J. Bleyer, J. Hartman, P. C. Brannon, A. Reeves-Daniel, S. G. Satko, and G. Russell, “Characteristics of sudden death in hemodialysis patients,” Kidney International, vol. 69, no. 12, pp. 2268–2273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. C. de Oliveira, M. Martinelli, S. A. Nishioka et al., “Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial,” Circulation: Arrhythmia and Electrophysiology, vol. 2, pp. 29–34, 2009. View at Google Scholar